EXACT Sciences

EXAS

Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer. Exact Sciences Corp. launched Cologuard in 2014, the first stool DNA test for colorectal cancer. The company was founded in 1995 in Marlborough, Massachusetts, bu …

Insider trades and stock quote 2023-2025

All insider trades at EXACT Sciences

Subscribe RSS
DateTypeInsiderPositionØ-PriceVolume
10/9/2025 SellDoyle, James Edward Director $60.0 $120,000
10/9/2025 SellHerriott, James SVP, General Counsel & Sec $60.0 $90,000
8/13/2025 SellDoyle, James Edward Director $42.0 $62,400
6/13/2025 SellZanotti, Katherine S. Director $53.2 $170,612
11/13/2024 BuyConroy, Kevin T. President and CEO $51.4 $1,001,325
All information without guarantee! No recommendation/consultation! © U.S. Securities and Exchange Commission (SEC)